Target intelligence / Profile preview

Zinc finger protein SNAI2 (SNAI2)

Target
SNAI2
Molecular classification
Transcription factor, C2H2-type zinc finger protein
01

Overview

Zinc finger protein SNAI2 (SNAI2, also known as SLUG) is a transcriptional repressor belonging to the Snail family of C2H2-type zinc finger transcription factors, encoded by the SNAI2 gene on human chromosome 8[1][6]. SNAI2 plays a crucial role in promoting epithelial to mesenchymal transition (EMT), a process essential for embryonic development, tissue repair, and tumor metastasis[1]. It binds to E-box DNA motifs to repress transcription of key adhesion molecules such as E-cadherin, facilitating cell migration and the acquisition of mesenchymal traits[1][6]. SNAI2 is critically important for neural crest cell development, influencing the differentiation and migration of these cells and contributing to the formation of various tissues including nerve and pigment cells (melanocytes)[2][3]. Mutations or deletions in SNAI2 are associated with disorders such as Waardenburg syndrome type II and piebaldism, both characterized by defects in pigmentation and, in Waardenburg syndrome, hearing loss[3]. In adults, SNAI2 functions in most tissues and maintains normal cellular function; dysregulated expression has been linked to cancer progression, particularly by promoting mesenchymal characteristics in carcinoma cells and enhancing metastatic potential[1][4]. **Note:** - No approved drugs are currently known to directly target SNAI2, and it primarily serves as a biomarker and a mechanistic node in EMT and oncogenesis[6]. - SNAI2 is a well-established transcription factor/therapeutic target by virtue of its roles in development and cancer, but it may present significant safety risks if targeted systemically due to broad developmental and homeostatic functions[1][3].

Other names
SLUGSLUGHSLGHSLUGH1SNAIL2neural crest transcription factor Slugprotein snail homolog 2snail 2snail family zinc finger 2slug homologSLUG_HUMANWS2D
02

Biological functions

Epithelial-mesenchymal transition (EMT)Transcriptional repressionRegulation of neural crest cell migrationRegulation of differentiationAnti-apoptosisCell proliferationEmbryonic developmentRegulation of cell fate
03

Disease associations

CancerLeukemiaPiebaldismWaardenburg syndrome (type II)Neural tube defectsOther pigmentary/embryonic disorders
04

Safety considerations

Inhibition or dysregulation may disrupt embryonic development, particularly neural crest differentiation and melanocyte survivalpotential impact on tissue regeneration or normal anti-apoptotic function
05

Biomarkers

Downregulation of E-cadherin (for EMT)SNAI2 mRNA/protein expression (for EMT and tumor progression)

Beyond the preview

Go deeper on Zinc finger protein SNAI2 (SNAI2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein SNAI2 (SNAI2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call